day 2: track 2, patient’s role, dave leventhal (pfizer) jane larkindale, jeffrey sherman,
Published 8 years ago • 183 plays • Length 41:39Download video MP4
Download video MP3
Similar videos
-
7:36
introducing remission - type 2 diabetes
-
1:07
promising investigational car-t approaches for myeloma: dual-targeted car-t products
-
2:25
a phase ii adaptive study of dasatinib and inotuzumab-based induction for newly diagnosed ph all
-
6:22
conavi medical unveils next-gen dual-modality catheter for cardiac interventions
-
1:46
assessing financial toxicity of car-t therapy in myeloma and improving access to this treatment
-
2:43
24-hour urine testing does not add value to multiple myeloma response assessments
-
2:37
the importance of secondary cancer screening programs in hodgkin lymphoma survivors
-
0:53
glp-1 agonists and sglt-2 inhibitors for treating adults with scd and nephropathy
-
4:40
can a continuous glucose monitor (cgm) be used to improve skin health and appearance?
-
1:35
key predictors of success when administering car-t for dlbcl
-
1:04:00
december 6, 2024 vmr with rabih & cps team - fall
-
3:04
the logistical challenges of car t-cell therapy in non-hodgkin lymphoma
-
51:58
vsm webinars 2/2024 : hybrid approach in clti
-
2:04
the impact and value of whole genome sequencing in multiple myeloma
-
4:15
cardiology | braunwald series | cardiac tumors | raaonline
-
0:33
valproic acid found clinical use as an anticonvulsant and mood-stabilizing drug that has proven use…
-
5:11
the cardiac wire show - circle cardiovascular imaging's cardiac ct expansion
-
0:32
döhle bodies on peripheral blood smear #hemepath #hematology #pathology
-
21:52
final chapter: a vision for the future digital therapeutics innovations part ii.